Skip to main content
. 2016 Mar 11;6:22976. doi: 10.1038/srep22976

Figure 4.

Figure 4

(A) Overall survival (OS) between patients with high and low p-c-Jun expression treated with sorafenib (B) Kaplan-Meier survival analysis curve.